Clinical Trials Logo

Clinical Trial Summary

A double blind, prospective, randomized trial to evaluate postoperative pain, narcotic use, patient satisfaction, and function among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine.


Clinical Trial Description

In order to reduce narcotic abuse potential, orthopaedic surgeons have explored multimodal pain regimens in addition to regional anesthesia to improve postoperative pain control. One commonly used intervention to reduce postoperative shoulder pain has been the interscalene brachial plexus block. This block provides significant pain relief for shoulder procedures, but has been limited to less than 24 hours even with long acting anesthetics. In the setting of shoulder arthroplasty, this short-term pain control often leads to the need for increased narcotic pain medication. Since shoulder arthroplasty has been steadily increasing in the United States with an annual growth rate of 10.6%, it is imperative to control patients' postoperative pain without increasing their risk for opiate abuse. A potential method for achieving this is by using liposomal bupivacaine in the interscalene blocks. This study is a double blind, prospective, randomized trial to evaluate the postoperative pain profiles among shoulder arthroplasty patients receiving interscalene block with and without the addition of liposomal bupivacaine. The purpose of this study is to determine if patients undergoing shoulder arthroplasty with an interscalene brachial plexus block with liposomal bupivacaine (study group) or without liposomal bupivacaine (control group) will have differences in postoperative opiate consumption, patient-reported pain, satisfaction with surgery, and shoulder function. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05068960
Study type Interventional
Source Scripps Clinic
Contact Heinz Hoenecke, MD
Phone 858.554.7993
Email [email protected]
Status Recruiting
Phase Phase 4
Start date March 1, 2021
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT01430468 - Patient Specific Instruments Versus Standard Surgical Instruments N/A
Completed NCT03730597 - Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study N/A
Completed NCT01782872 - Analgesia After Total Shoulder Arthroplasty Phase 4
Active, not recruiting NCT03623269 - Posterior Approach to Total Shoulder Arthroplasty
Terminated NCT03219983 - Pain Management After Total Shoulder Arthroplasty Phase 4
Completed NCT01726972 - A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Enrolling by invitation NCT04416932 - Ultrasound After Total Shoulder Arthroplasty
Recruiting NCT04855019 - Post Surgical Pain in Arthroscopic Shoulder N/A
Recruiting NCT02143245 - Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections N/A
Not yet recruiting NCT04364867 - Exparel for Total Shoulder Arthroplasty Phase 4
Recruiting NCT03887650 - LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs Phase 4
Completed NCT01550952 - Interscalene Dynamometer Pilot Study N/A